Literature DB >> 10940315

Regulation of connexin degradation as a mechanism to increase gap junction assembly and function.

L S Musil1, A C Le, J K VanSlyke, L M Roberts.   

Abstract

Connexins, the integral membrane protein constituents of gap junctions, are degraded at a rate (t(12) = 1.5-5 h) much faster than most other cell surface proteins. Although the turnover of connexins has been shown to be sensitive to inhibitors of either the lysosome or of the proteasome, how connexins are targeted for degradation and whether this process can be regulated to affect intercellular communication is unknown. We show here that reducing connexin degradation with inhibitors of the proteasome (but not with lysosomal blockers) is associated with a striking increase in gap junction assembly and intercellular dye transfer in cells inefficient in both processes under basal conditions. The effect of proteasome inhibitors on wild-type connexin stability, assembly, and function was mimicked by treatment of assembly-inefficient cells with inhibitors of protein synthesis such as cycloheximide. Sensitivity of connexin degradation to cycloheximide, but not to proteasome inhibitors, was abolished when connexins were rendered structurally abnormal by perturbation of essential disulfide bonds or by mutation. Our findings provide the first evidence that intercellular communication can be up-regulated at the level of connexin turnover and that a short-lived protein may be required for conformationally mature connexins to become substrates of proteasomal degradation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10940315     DOI: 10.1074/jbc.275.33.25207

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  76 in total

Review 1.  Developmental regulation of gap junctions and their role in mammary epithelial cell differentiation.

Authors:  Marwan E El-Sabban; Lina F Abi-Mosleh; Rabih S Talhouk
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

2.  Developmental truncations of connexin 50 by caspases adaptively regulate gap junctions/hemichannels and protect lens cells against ultraviolet radiation.

Authors:  Ke Wang; Sumin Gu; Xinye Yin; Susan T Weintraub; Zichun Hua; Jean X Jiang
Journal:  J Biol Chem       Date:  2012-03-14       Impact factor: 5.157

Review 3.  Degradation of connexins through the proteasomal, endolysosomal and phagolysosomal pathways.

Authors:  Vivian Su; Kimberly Cochrane; Alan F Lau
Journal:  J Membr Biol       Date:  2012-07-08       Impact factor: 1.843

4.  Regulation of nicotinic receptor expression by the ubiquitin-proteasome system.

Authors:  John C Christianson; William N Green
Journal:  EMBO J       Date:  2004-10-14       Impact factor: 11.598

5.  Androgen-regulated formation and degradation of gap junctions in androgen-responsive human prostate cancer cells.

Authors:  Shalini Mitra; Lakshmanan Annamalai; Souvik Chakraborty; Kristen Johnson; Xiao-Hong Song; Surinder K Batra; Parmender P Mehta
Journal:  Mol Biol Cell       Date:  2006-10-18       Impact factor: 4.138

Review 6.  Life cycle of connexins in health and disease.

Authors:  Dale W Laird
Journal:  Biochem J       Date:  2006-03-15       Impact factor: 3.857

7.  The C-terminus of connexin43 adopts different conformations in the Golgi and gap junction as detected with structure-specific antibodies.

Authors:  Gina E Sosinsky; Joell L Solan; Guido M Gaietta; Lucy Ngan; Grace J Lee; Mason R Mackey; Paul D Lampe
Journal:  Biochem J       Date:  2007-12-15       Impact factor: 3.857

8.  Conformational maturation and post-ER multisubunit assembly of gap junction proteins.

Authors:  Judy K Vanslyke; Christian C Naus; Linda S Musil
Journal:  Mol Biol Cell       Date:  2009-03-18       Impact factor: 4.138

Review 9.  Breaking down protein degradation mechanisms in cardiac muscle.

Authors:  Robert C Lyon; Stephan Lange; Farah Sheikh
Journal:  Trends Mol Med       Date:  2013-02-27       Impact factor: 11.951

10.  Connexins and apoptotic transformation.

Authors:  Audrone Kalvelyte; Ausra Imbrasaite; Angele Bukauskiene; Vytas K Verselis; Feliksas F Bukauskas
Journal:  Biochem Pharmacol       Date:  2003-10-15       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.